Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 4, 2012, Pages 830-837

  Milano, Aldo Domenico ^a   Faggian, Giuseppe ^a   Dodonov, Mikhail ^a   Golia, Giorgio ^a   Tomezzoli, Anna ^a   Bortolotti, Uberto ^b   Mazzucco, Alessandro ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CAUSE OF DEATH; CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART DILATATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART STRESS; HEART VALVE PROSTHESIS; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HUMAN; INDEPENDENT VARIABLE; LEFT VENTRICULAR ENDSYSTOLIC WALL STRESS; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOPSY; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; FIBROSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIUM; PROPORTIONAL HAZARDS MODELS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR SEPTUM;

EID: 84866357052     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.11.024     Document Type: Article

References (39)

1. B.A. Carabello, and W.J. Paulus Aortic stenosis Lancet 373 2009 956 966
2. W. Grossman, D. Jones, and L.P. McLaurin Wall stress and patterns of hypertrophy in the human left ventricle J Clin Invest 56 1975 56 64
3. J. Chambers The left ventricle in aortic stenosis: evidence for the use of ACE inhibitors Heart 92 2006 420 423
4. M. Kupari, H. Turto, and J. Lommi Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 26 2005 1790 1796
5. S. Hein, E. Arnon, S. Kostin, M. Schonburg, A. Elsasser, and V. Polyakova Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms Circulation 107 2003 984 991
6. K.T. Weber From inflammation to fibrosis: a stiff stretch of highway Hypertension 43 2004 716 719
7. G.G. Serneri, P.A. Modesti, M. Boddi, I. Cecioni, R. Paniccia, and M. Coppo Cardiac growth factors in human hypertrophy: relations with myocardial contractility and wall stress Circ Res 85 1999 57 67
8. Z. Hachicha, J.G. Dumesnil, P. Bogaty, and P. Pibarot Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival Circulation 115 2007 2856 2864
9. F. Weidemann, S. Herrmann, S. Stork, M. Niemann, S. Frantz, and V. Lange Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis Circulation 120 2009 577 584
10. C.F. Azevedo, M. Nigri, M.L. Higuchi, P.M. Pomerantzeff, G.S. Spina, and R.O. Sampaio Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease J Am Coll Cardiol 56 2010 278 287
11. S. Herrmann, S. Stork, M. Niemann, V. Lange, J.M. Strotmann, and S. Frantz Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome J Am Coll Cardiol 58 2011 402 412
12. H. Baumgartner, J. Hung, J. Bermejo, J.B. Chambers, A. Evangelista, and B.P. Griffin Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice Eur J Echocard 10 2009 1 25
13. R.B. Devereux, and N. Reichek Echocardiographic determination of left ventricular mass in man: anatomic validation of the method Circulation 55 1977 613 618
14. N. Reichek, J. Wilson, S.M. St John, T.A. Plappert, S. Goldberg, and J.W. Hirshfeld Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application Circulation 65 1982 99 108
15. U. Baandrup, R.A. Florio, M. Rehahn, P.J. Richardson, and E.G. Olsen Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. II: comparison of histology and clinical/haemodynamic information Br Heart J 45 1981 487 493
16. O. Lund Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis: reasons for earlier operative intervention Circulation 82 1990 124 139
17. M. Tanaka, H. Fujiwara, T. Onodera, D.J. Wu, Y. Hamashima, and C. Kawai Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy Br Heart J 55 1986 575 581
18. U. Baandrup, R.A. Florio, and E.G. Olsen Do endomyocardial biopsies represent the morphology of the rest of the myocardium? A quantitative light microscopic study of single vs multiple biopsies with the King's bioptome Eur Heart J 3 1982 171 178
19. O. Lund, L.H. Kristensen, U. Baandrup, O.K. Hansen, T.T. Nielsen, and K. Emmertsen Myocardial structure as a determinant of pre- and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis Eur Heart J 19 1998 1099 1108
20. C.W. Akins, D.C. Miller, M.I. Turina, N.T. Kouchoukos, E.H. Blackstone, and G.L. Grunkemeier Guidelines for reporting mortality and morbidity after cardiac valve interventions J Thorac Cardiovasc Surg 135 2008 732 738
21. H.P. Krayenbuehl, O.M. Hess, E.S. Monrad, J. Schneider, G. Mall, and M. Turina Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement Circulation 79 1989 744 755
22. B.J. Maron, V.J. Ferrans, and W.C. Roberts Myocardial ultrastructure in patients with chronic aortic valve disease Am J Cardiol 35 1975 725 739
23. S. Heymans, B. Schroen, P. Vermeersch, H. Milting, F. Gao, and A. Kassner Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart Circulation 112 2005 1136 1144
24. J. Fielitz, S. Hein, V. Mitrovic, R. Pregla, H.R. Zurbrugg, and C. Warnecke Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease J Am Coll Cardiol 37 2001 1443 1449
25. T. Walther, A. Schubert, V. Falk, C. Binner, C. Walther, and N. Doll Left ventricular reverse remodeling after surgical therapy for aortic stenosis: correlation to renin-angiotensin system gene expression Circulation 106 2002 I23 I26
26. S. Helske, M. Laine, M. Kupari, J. Lommi, H. Turto, and L. Nurmi Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves Eur Heart J 28 2007 1894 1903
27. H. Kitaoka, T. Kubo, M. Okawa, K. Hayato, N. Yamasaki, and Y. Matsumura Impact of metalloproteinases on left ventricular remodeling and heart failure events in patients with hypertrophic cardiomyopathy Circ J 74 2010 1191 1196
28. T. Mihaljevic, E.R. Nowicki, J. Rajeswaran, E.H. Blackstone, L. Lagazzi, and J. Thomas Survival after valve replacement for aortic stenosis: implication for decision making J Thorac Cardiovasc Surg 135 2008 1270 1279
29. A. Ali, A. Patel, Z. Ali, Y. Abu-Omar, A. Saeed, and T. Athanasiou Enhanced left ventricular mass regression after aortic valve replacement in patients with aortic stenosis is associated with improved long-term survival J Thorac Cardiovasc Surg 142 2011 285 291
30. O.M. Hess, M. Ritter, J. Schneider, J. Grimm, M. Turina, and H.P. Krayenbuehl Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement Circulation 69 1984 855 865
31. D.H. MacIver, and M. Townsend A novel mechanism of heart failure with normal ejection fraction Heart 94 2008 446 449
32. R.J. Kim, E. Wu, A. Rafael, E.L. Chen, M.A. Parker, and O. Simonetti The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
33. A. Wagner, H. Mahrholdt, T.A. Holly, M.D. Elliott, M. Regenfus, and M. Parker Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study Lancet 361 2003 374 379
34. A.S. Flett, M.P. Hayward, M.T. Ashworth, M.S. Hansen, A.M. Taylor, and P.M. Elliott Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
35. C.M. Kramer Cardiac magnetic resonance imaging identification of myocardial fibrosis: the need for standardization and therapies J Am Coll Cardiol 56 2010 288 289
36. N. Mewton, C.Y. Liu, P. Croisille, D. Bluemke, and J.A.C. Lima Assessment of myocardial fibrosis with cardiovascular magnetic resonance J Am Coll Cardiol 57 2011 891 903
37. L. Iles, H. Pfluger, A. Phrommintikul, J. Cherayath, P. Aksit, and S.N. Gupta Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580
38. J.C. Moon, E. Reed, M.N. Sheppard, A.G. Elkington, S.Y. Ho, and M. Burke The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
39. D.P. Leong, P.L. Madsen, and J.B. Selvanayagam Non-invasive evaluation of myocardial fibrosis: implications for the clinician Heart 96 2010 2016 2024